Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD)
Displaying entries 2001 - 2025 of 2342 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AU04
  • Fucalpha1-2Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • Ley-A-9(d18:1/22:0)
44260775 2114.149772 C98H175N3O45
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AI01
  • Fucalpha1-2Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • Leb(d18:1/16:0)
44260676 1518.865763 C72H130N2O31
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AQ03
  • Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • Isoglobotriglycosylceramide(d18:1/20:0)
44261566 1079.733169 C56H105NO18
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CP05
  • Fucalpha1-2Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44261504 2215.197451 C102H182N4O47
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AZ00
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4Glcbeta-Cer
GSG1356
Simple Glc series LMSP0501AA10
  • GlcCer(d18:1/26:1(17Z))
  • N-(17Z-hexacosenoyl)-1-beta-glucosyl-sphing-4-enine
6321362 84750 837.705769 C50H95NO8
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AR05
  • GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260752 1688.012427 C82H149N3O32
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AJ02
  • GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • type IV A antigen(d18:1/18:0)
44260237 1765.971352 C82H147N3O37
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BD07
  • Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • Lex-9(d18:1/24:1(15Z))
44261210 2213.181801 C102H180N4O47
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AP00
  • GalNAcbeta1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
GSG1198
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505DX00
  • Fucalpha1-2(GalNAcalpha1-3)Galbeta1-4GlcNAcbeta1-3(Fucalpha1-2Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CV01
  • Gala 1-3Lex(d18:1/16:0)
  • Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261548 1534.860678 C72H130N2O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AY00
  • GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer
GSG1394
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505EP06
  • B-IV antigen(d18:1/26:0)
  • Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44261849 3078.52451 C136H239N5O71
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BX04
  • Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261367 2568.293265 C114H201N5O58
Manalpha1-3Manbeta1-4Glc- (Mollu series) LMSP0507AA07
  • Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261946 1133.780119 C60H111NO18
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BZ02
  • Galalpha1-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3(GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44261381 2877.362864 C124H216N6O68
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AP06
  • GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44260737 2081.175926 C98H176N4O42
Simple Glc series LMSP0501AA67
  • GlcCer(d14:1(4E)/22:1(13Z)(2OH))
  • N-(2-hydroxy-13Z-docosenoyl)-1-beta-glucosyl-tetradecasphing-4-enine
70699248 741.575484 C42H79NO9
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AS03
  • Fucalpha1-3GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44260758 1778.007737 C84H151N3O36
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AG03
  • Fucalpha1-3GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44260534 1631.949827 C78H141N3O32
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AA07
  • GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • asialo-GM2(d18:1/24:1(15Z))
44260490 1174.806668 C62H114N2O18
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AQ07
  • Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • Isoglobotriglycosylceramide(d18:1/24:1(15Z))
44261570 1133.780119 C60H111NO18
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AD02
  • Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • type II antigen(d18:1/18:0)
44260997 1400.839153 C68H124N2O27
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AN01
  • Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260268 1509.829044 C70H127NO33

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024